tiprankstipranks
Xtacy Therapeutics Corp. (XTCYF)
:XTCYF
US Market
Holding XTCYF?
Track your performance easily

Xtacy Therapeutics (XTCYF) Financial Statements

4 Followers

Xtacy Therapeutics Financial Overview

Xtacy Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.002; its P/E ratio is ―; Xtacy Therapeutics is scheduled to report earnings on January 29, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit---$ 24.25K$ -2.78K
EBIT$ -120.74K$ -63.06K$ -263.44K$ 256.89K$ -395.51K
EBITDA$ -120.74K$ -63.06K$ -263.44K$ 256.89K$ -395.51K
Net Income Common Stockholders$ -123.42K$ -65.73K$ -265.84K$ 259.31K$ -398.29K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 357.36K$ 445.38K$ 332.49K$ 367.44K-
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 700.97K$ 844.59K$ 665.96K$ 703.15K-
Stockholders Equity$ -343.60K$ -1.34M$ -333.48K$ -335.71K$ ―
Cash Flow-
Free Cash Flow$ -551.93K--$ -216.70K$ 309.39K
Operating Cash Flow$ -551.93K--$ -216.70K$ 309.39K
Investing Cash Flow-----
Financing Cash Flow---$ 216.70K$ -104.60K
Currency in USD

Xtacy Therapeutics Earnings and Revenue History

Xtacy Therapeutics Debt to Assets

Xtacy Therapeutics Cash Flow

Xtacy Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis